BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baldassi D, Ambike S, Feuerherd M, Cheng CC, Peeler DJ, Feldmann DP, Porras-Gonzalez DL, Wei X, Keller LA, Kneidinger N, Stoleriu MG, Popp A, Burgstaller G, Pun SH, Michler T, Merkel OM. Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes. J Control Release 2022;345:661-74. [PMID: 35364120 DOI: 10.1016/j.jconrel.2022.03.051] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Jingran Chen, Ying Li, Zhen Liu. Functional nucleic acids as potent therapeutics against SARS-CoV-2 infection. Cell Rep Phys Sci 2023:101249. [ DOI: 10.1016/j.xcrp.2023.101249] [Reference Citation Analysis]
2 Gholizadeh O, Yasamineh S, Amini P, Afkhami H, Delarampour A, Akbarzadeh S, Karimi Matloub R, Zahedi M, Hosseini P, Hajiesmaeili M, Poortahmasebi V. Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview. Virol J 2022;19:206. [PMID: 36463213 DOI: 10.1186/s12985-022-01935-7] [Reference Citation Analysis]
3 Wang H, Qin L, Zhang X, Guan J, Mao S. Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery. J Control Release 2022;352:970-93. [PMID: 36372386 DOI: 10.1016/j.jconrel.2022.10.061] [Reference Citation Analysis]
4 Baldassi D, Ngo TMH, Merkel OM. Optimization of Lung Surfactant Coating of siRNA Polyplexes for Pulmonary Delivery. Pharm Res 2022;:1-15. [PMID: 36447020 DOI: 10.1007/s11095-022-03443-3] [Reference Citation Analysis]
5 Costa VG, Costa SM, Saramago M, Cunha MV, Arraiano CM, Viegas SC, Matos RG. Developing New Tools to Fight Human Pathogens: A Journey through the Advances in RNA Technologies. Microorganisms 2022;10:2303. [DOI: 10.3390/microorganisms10112303] [Reference Citation Analysis]
6 Steffens RC, Wagner E. Directing the Way—Receptor and Chemical Targeting Strategies for Nucleic Acid Delivery. Pharm Res. [DOI: 10.1007/s11095-022-03385-w] [Reference Citation Analysis]
7 Monroe MK, Wang H, Anderson CF, Jia H, Flexner C, Cui H. Leveraging the therapeutic, biological, and self-assembling potential of peptides for the treatment of viral infections. J Control Release 2022:S0168-3659(22)00378-9. [PMID: 35752254 DOI: 10.1016/j.jconrel.2022.06.037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kianpour M, Akbarian M, Uversky VN. Nanoparticles for Coronavirus Control. Nanomaterials (Basel) 2022;12:1602. [PMID: 35564311 DOI: 10.3390/nano12091602] [Reference Citation Analysis]